Vascular Biogenics Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vascular Biogenics Ltd. generated cash of -$31,594,000, which is less than the previous year. Cash used in financing activities reached the amount of $22,000 last year. Net change in cash is therefore -$4,323,000.
Cash Flow
| 2013 | -13.12M | 6.47M | 10M |
|---|---|---|---|
| 2014 | -13.70M | 1.43M | 40.08M |
| 2015 | -13.20M | -30.09M | 13.74M |
| 2016 | -13.41M | -4.09M | 21.98M |
| 2017 | -3.82M | -20.84M | 19.51M |
| 2018 | -15.68M | 24.73M | 13.67M |
| 2019 | -12.69M | -6.6M | -757K |
| 2020 | -23.37M | 9.89M | 17.06M |
| 2021 | -24.98M | -15.48M | 49.10M |
| 2022 | -31.59M | 27.29M | 22K |
VBLT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 22.34M | 13.69M | 9.94M | 29.34M | 6.69M | 11.58M | 7.09M | 36.78M | 9.37M | 5.93M |
Operating activities | ||||||||||
Net income | -32.30M | -29.92M | -24.22M | -19.45M | -20.45M | -10.13M | -16.00M | -14.88M | -17.40M | -17.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.05M | 1.25M | 1.19M | 1.71M | 1.15M | 156K | 130K | 122K | 135K | 169K |
Stock-based compensation expense | 2.55M | 1.96M | 1.66M | 2.25M | 3.86M | 4.15M | 1.42M | 1.04M | 2.61M | 494K |
| Deferred income tax benefit | 2.55M | 1.96M | 1.66M | 2.25M | 3.86M | 4.15M | 1.42M | 1.04M | 2.61M | 494K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 129K | -129K | 0 | 2M | -2M | 0 | 0 | 0 | 0 |
Inventories | 0 | -26K | 103K | 0 | -19K | 790K | 0 | 0 | 0 | 0 |
Accounts payable | -3.52M | 2.37M | -1.37M | 2.13M | -1.69M | 421K | 472K | 1.35M | -653K | 39K |
Cash generated by operating activities | -31.59M | -24.98M | -23.37M | -12.69M | -15.68M | -3.82M | -13.41M | -13.20M | -13.70M | -13.12M |
Investing activities | ||||||||||
Purchases Of Investments | -3M | -51.10M | -41.08M | -63.52M | -21M | -81.33M | -3.6M | -30M | 0 | 0 |
Investments In Property Plant And Equipment | -812K | -1.46M | -51K | -73K | -2.22M | -6.48M | -491K | -90K | -57K | -32K |
Acquisitions Net | -28.10M | 0 | 0 | 0 | 0 | 14.35M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 27.29M | -15.48M | 9.89M | -6.6M | 24.73M | -20.84M | -4.09M | -30.09M | 1.43M | 6.47M |
Financing activities | ||||||||||
Common Stock Issued | 22K | 34.75M | 17.45M | 2K | 13.72M | 19.03M | 21.85M | 13.65M | 34.87M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -104K | -391K | 0 | -88K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 22K | 49.10M | 17.06M | -757K | 13.67M | 19.51M | 21.98M | 13.74M | 40.08M | 10M |
Net Change In Cash | -4.32M | 8.65M | 3.75M | -19.91M | 22.65M | -4.89M | 4.49M | -29.69M | 27.40M | 3.44M |
Cash at end of period | 18.02M | 22.34M | 13.69M | 9.43M | 29.34M | 6.69M | 11.58M | 7.09M | 36.78M | 9.37M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |